Skip to main content

Table 3 Comparative analytical resulted data for determination of BUD and AZL in pure form by the proposed HPLC and comparison methods

From: Insights of different analytical approaches for estimation of budesonide as COVID-19 replication inhibitor in its novel combinations: green assessment with AGREE and GAPI approaches

Parameter

BUD

AZL

Proposed method

Comparison method [13]

Proposed method

Comparison method [40]

\(\overline{\text{X}}\) ± SD

100.29 ± 0.75

99.95 ± 1.36

99.85 ± 0.84

99.61 ± 0.98

t-value

0.58 (1.81)

0.45 (1.81)

F-value

3.28 (4.35)

1.37 (4.35)

  1. Each result is the mean recovery of three separate determinations
  2. Figures between brackets are the tabulated t and F-values at (P = 0.05)